» Articles » PMID: 12354372

Suicide in Neurologic Illness

Overview
Specialty Neurology
Date 2002 Oct 2
PMID 12354372
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The risk of attempted or completed suicide is increased in patients with migraine with aura, epilepsy, stroke, multiple sclerosis, traumatic brain injury, and Huntington's disease. Contrary to the general perception that the risk of suicide among patients with Alzheimer's disease and other dementing conditions is low, several reports suggest that the risk of suicide in these patients increases relative to the general population. Some patients at risk for neurologic disorders are also at increased risk for suicide; in particular, the risk of suicide is increased among persons at risk for Huntington's disease, independent of the presence or absence of the Huntington's gene mutation. The risk of attempted or completed suicide in neurologic illness is strongly associated with depression, feelings of hopelessness or helplessness, and social isolation. Additional suicide risk factors in persons with neurologic illness include cognitive impairment, relatively younger age (under 60 years), moderate physical disability, recent onset or change in illness, a lack of future plans or perceived meaning in life, recent losses (personal, occupational, or financial), and prior history of psychiatric illness or suicidal behavior. Substance dependence, psychotic disorders, anxiety disorders, and some personality disorders (eg, borderline personality disorder) may also contribute to increased risk of suicide among persons with neurologic illnesses. Identification and aggressive treatment of psychiatric problems, especially depression, as well as reduction of modifiable suicide risk factors among patients with neurologic illness is needed to reduce the risk of attempted and completed suicide in this population.

Citing Articles

Neurodevelopmental Disorders and Suicide: A Narrative Review.

Gagliano A, Costanza C, Di Modica I, Carucci S, Donno F, Germano E J Clin Med. 2024; 13(6).

PMID: 38541853 PMC: 10970742. DOI: 10.3390/jcm13061627.


Psychiatric Comorbidities in Functional Movement Disorders: A Retrospective Cohort Study.

Macchi Z, Kletenik I, Olvera C, Holden S Mov Disord Clin Pract. 2021; 8(5):725-732.

PMID: 34307745 PMC: 8287186. DOI: 10.1002/mdc3.13226.


Suicidality in Epilepsy: Does It Share Common Pathogenic Mechanisms with Epilepsy?.

Hecimovic H, Popovic Z, Gilliam F Curr Top Behav Neurosci. 2021; 55:209-250.

PMID: 33683680 DOI: 10.1007/7854_2021_220.


Suicidality Assessment of the Elderly With Physical Illness in the Emergency Department.

Costanza A, Amerio A, Radomska M, Ambrosetti J, Di Marco S, Prelati M Front Psychiatry. 2020; 11:558974.

PMID: 33024437 PMC: 7516267. DOI: 10.3389/fpsyt.2020.558974.


Psychological Interventions for People with Huntington's Disease: A Call to Arms.

Zarotti N, Dale M, Eccles F, Simpson J J Huntingtons Dis. 2020; 9(3):231-243.

PMID: 32894248 PMC: 7683059. DOI: 10.3233/JHD-200418.


References
1.
Parker G, Roy K, Hadzi-Pavlovic D, Pedic F . Psychotic (delusional) depression: a meta-analysis of physical treatments. J Affect Disord. 1992; 24(1):17-24. DOI: 10.1016/0165-0327(92)90056-c. View

2.
Kant R, Coffey C, Bogyi A . Safety and efficacy of ECT in patients with head injury: a case series. J Neuropsychiatry Clin Neurosci. 1999; 11(1):32-7. DOI: 10.1176/jnp.11.1.32. View

3.
Kessler S . Psychiatric implications of presymptomatic testing for Huntington's disease. Am J Orthopsychiatry. 1987; 57(2):212-219. DOI: 10.1111/j.1939-0025.1987.tb03531.x. View

4.
Stenager E, Koch-Henriksen N, Stenager E . Risk factors for suicide in multiple sclerosis. Psychother Psychosom. 1996; 65(2):86-90. DOI: 10.1159/000289052. View

5.
Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter J, Conneally P . Suicide risk in Huntington's disease. J Med Genet. 1993; 30(4):293-5. PMC: 1016335. DOI: 10.1136/jmg.30.4.293. View